spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MANTA 

 HSMN NewsFeed - 9 Oct 2017
The MANTA Large Bore Vascular Closure Device to be Evaluated in a 500-patient European Post Market Clinical Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Jun 2017
Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Dec 2016
Essential Medical Inc. Announces the Successful Initiation of the U.S. MANTA Vascular Closure Device Trial With the First Patients Enrolled in TAVR and EVAR Cases
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Jul 2016
Essential Medical Inc. Announces CE Mark Approval for the MANTA(TM) Large Bore Vascular Closure Device
Devices Interventional Regulatory
 HSMN NewsFeed - 8 Jul 2016
Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA(TM) Large Bore Vascular Closure Device
Devices Interventional FDA
 HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 13 May 2014
Gemmus Pharma Closes $3.3M Series B Funding to Develop Superior Flu Drug
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Mar 2013
Adamas Pharmaceuticals Presents New Traumatic Brain Injury Data From Its Nurelin(TM) Program At American Academy Of Neurology Conference
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Nov 2012
Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR(R) and Donepezil for Alzheimer’s Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 2 Nov 2011
Integra LifeSciences Launches a Zero-Profile, Stand-Alone Interbody Device for Neck Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Oct 2011
Integra LifeSciences Launches an Anterior Cervical Plating System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 29 Jul 2010
Shionogi Inc. Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Aug 2009
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2009
Adamas Pharmaceuticals Raises $40 Million in Series D Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 7 May 2009
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Dec 2008
Management changes at RaySearch
Devices Oncology Personnel
 HSMN NewsFeed - 2 Jun 2008
Banner Pharmacaps Receives FDA Approval for Amantadine Softgel Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Apr 2008
Early Study Results Demonstrate Ability of Innovative RF Ablation Catheter to Quickly and Easily Isolate Pulmonary Veins in Atrial Fibrillation Patients
Devices Cardiology
 HSMN NewsFeed - 7 Jan 2008
Access Pharmaceuticals Closes Acquisition of Somanta Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Dec 2007
Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2007
Access Pharmaceuticals Announces $19.5 Million Recapitalization
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2007
Sequella Lead Drug Compound SQ109 Receives Orphan Drug Status From the US FDA and Orphan Medicinal Product Designation From the European Medicines Agency for the Treatment of Tuberculosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Apr 2007
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2007
Access Pharmaceuticals Signs Letter of Intent to Acquire Somanta Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 3 additional stories matching:
MANTA
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.